logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
P

Ping Zhang

college of desertification control science and engineering
H指数:35
被引数:6,518

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Context-specific regulatory genetic variation in MTOR dampens neutrophil-T cell crosstalk in pneumonia-associated sepsis

MTOR中与特定环境相关的调控性遗传变异会削弱肺炎相关败血症中的中性粒细胞-淋巴细胞相互作用

Nature Communications
IF15.7
2026-02-250
OAAI
Ping Zhang; Patrick MacLean; Alicia Jia; Callum R. O’Neill; Alice Allcock; Ethan Prince; Bora Ozcan; Roman M. Doll; Imogen Dyne; Kiki Cano-Gamez; Hanyu Qin; Chloe Wainwright; Giuseppe Scozzafava; Andrew C. Brown; James O. J. Davies; Amanda Y. Chong; Alexander J. Mentzer; Katie L. Burnham; Emma E. Davenport; Julian C. Knight
Evolution of the tuberculin skin test reveals generalisable Mtb-reactive T cell metaclones

结核菌素皮肤试验的进展揭示了可推广的Mtb反应性T细胞metaclones

Nature Communications
IF15.7
2026-01-210
OAAI
Carolin T. Turner; Andreas Tiffeau-Mayer; Joshua Rosenheim; Aneesh Chandran; Rishika Saxena; Ping Zhang; Jana Jiang; Michelle Berkeley; Flora Pang; Imran Uddin; Gayathri Nageswaran; Suzanne Byrne; Akshay Karthikeyan; Werner Smidt; Paul Ogongo; Rachel Byng-Maddick; Santino Capocci; Marc Lipman; Heinke Kunst; Stefan Lozewicz; Veron Ramsuran; Gabriele Pollara; Julian C. Knight; Alasdair Leslie; Benjamin M. Chain; Mahdad Noursadeghi
Prognostic role of circRNAs and RNA methylation enzymes in bladder cancer: A systematic review and meta-analysis of Chinese studies

Ren, H.; Zou, L.; Jiang, L.; Zhang, P.; Li, C.; Li, Z.; Niu, H.; Zhang, X.; Liao, H.; Cheng, L.; et al. 环状RNA和RNA甲基化酶在膀胱癌中的预后作用：一项针对中国研究的系统评价和荟萃分析。Urol. Oncol. Semin. Orig. Investig. 2025, 43, 628–638. [Google Scholar] [CrossRef]

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
IF2.3
2025-09-011
PRE
Ren, Huanyu; Zou, Lina; Jiang, Lan; Zhang, Ping; Li, Chunmei; Li, Zheng; Niu, Huiru; Zhang, Xiaojing; Liao, Hao; Cheng, Lang; Yang, Feiyan; An, Shanshan; Ge, Xiuhong; Ren, Fei; Pan, Hongzhi; Rong, Shengzhong; Ma, Hongkun
Efficacy and safety of lucitanib (AL3810) in second or subsequent-line treatment of advanced recurrent or metastatic thymic carcinoma: A randomized, double-blind, placebo-controlled multicenter phase II trial

卢昔坦尼（AL3810）在二线或后续治疗晚期复发性或转移性胸腺癌中的疗效与安全性：一项随机、双盲、安慰剂对照的多中心II期临床试验

ANNALS OF ONCOLOGY
IF65.4
2024-12-010
PRE
Fang, W. V.; Wang, C.; Wu, K.; Fu, J.; Lin, X.; Zhang, H.; Chen, J.; Zhang, Y.; Zhang, P.; Liu, Y.; Zheng, Y.; Tang, P.; Gao, Z.; Fan, Q.; Zhi, X.; Cai, H.; Zheng, J.; Li, M.; Li, F.; Zhou, C.
Patient-reported outcomes (PROs) from the phase III EVOKE-01 trial of sacituzumab govitecan (SG) vs docetaxel (doc) in metastatic non-small cell lung cancer (mNSCLC)

来自sacituzumab govitecan (SG) 与 docetaxel (doc) 在转移性非小细胞肺癌 (mNSCLC) 中的III期EVOKE-01试验的患者报告结局 (PROs)

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Reinmuth, N.; Paz-Ares, L. G.; Garassino, M. C.; Baijal, S.; Bennouna, J.; Daniel, D. B.; Garrido Lopez, P.; Kato, T.; Percent, I.; Rittmeyer, A.; Parra, H. J. Soto; Mekan, S.; Patel, M.; Radford, M. A.; Zhang, P.; Pelligra, C. G.; Felip, E.

研究方向

暂未获取到该数据
J
Julian C. Knight
H 指数:91论文数:419被引数:4.5万
G
Gareth L. Bond
H 指数:29论文数:138被引数:5,008
C
Christine Blattner
H 指数:28论文数:143被引数:2,917
A
Andrew Brown
H 指数:14论文数:56被引数:1,562
A
Alice Allcock
H 指数:13论文数:44被引数:1,191
G
Giuseppe Scozzafava
H 指数:13论文数:51被引数:890
L
Lingyun Xiong
H 指数:21论文数:87被引数:1,589
G
Guang Xu
H 指数:28论文数:71被引数:2,462
M
Meng Xu
H 指数:40论文数:254被引数:5,835
Tao Dong 封面图
Tao Dong
H 指数:73论文数:480被引数:3.4万